Fertilisation

Fertilisation marks the beginning of human development. It begins with the deposition of millions of sperm into the vagina, which then travel through the cervical canal and uterus to the fallopian tubes. For fertilisation to be successful, sperm must undergo capacitation, a process of biochemical maturation within the female reproductive tract that enhances motility and prepares the sperm to penetrate the egg's layers. Once a sperm reaches the oocyte, it must navigate the corona radiata and bind to the zona pellucida. This binding triggers the acrosome reaction, releasing enzymes that allow the sperm to penetrate the zona pellucida and reach the oocyte's plasma membrane. Upon fusion of the two membranes, the oocyte completes its second meiotic division, and the cortical reaction occurs. The cortical reaction involves the release of lysosomal enzymes from cortical granules, which alters the zona pellucida to prevent other sperm from entering (polyspermy). The male and female pronuclei then fuse, forming the zygote with 46 chromosomes (23 pairs). This process not only initiates cleavage but also determines the chromosomal sex (XX or XY) and leads to the unique genetic combination of the new individual.

The molecular biology of fertilisation is highly regulated. Sperm capacitation involves the removal of a glycoprotein coat and seminal plasma proteins from the plasma membrane over the acrosomal region. The zona pellucida, a glycoprotein shell surrounding the egg, contains ZP3 receptors that act as species-specific binding sites for sperm. The acrosome reaction is a calcium-dependent process resulting in the fusion of the outer acrosomal membrane with the sperm's plasma membrane. Following fusion of the gametes, the oocyte's metabolic activity increases. The secondary oocyte, previously arrested in metaphase II, completes meiosis to produce a definitive oocyte and a second polar body. The chromosomes of the sperm and egg then decondense to form pronuclei. As these pronuclei replicate their DNA and their membranes break down, the first mitotic division begins. This leads to the two-cell stage of the embryo. Disruptions in any of these steps (e.g., failed acrosome reaction or polyspermy) result in non-viable embryos or early pregnancy loss.

Understanding fertilisation is critical for managing infertility and assisted reproductive technologies (ART), such as In Vitro Fertilisation (IVF) and Intracytoplasmic Sperm Injection (ICSI). Failure of natural fertilisation can result from tubal factors, sperm dysfunction, or ovulatory disorders. Ectopic pregnancy is a major clinical risk where fertilisation occurs correctly, but the zygote implants outside the uterine cavity, most commonly in the fallopian tube. Clinicians must be aware of the timeline of fertilisation to accurately date pregnancies and interpret beta-hCG levels. Genetic abnormalities arising during fertilisation, such as triploidy (often from polyspermy) or aneuploidy (nondisjunction), are high-yield topics for MLA finals as they relate to early miscarriage and congenital syndromes.

Investigations include semen analysis to assess sperm count and motility (WHO criteria), and hysterosalpingography to ensure tubal patency. For suspected early pregnancy or complications, serial serum beta-hCG levels and transvaginal ultrasound (TVS) are used to confirm intrauterine location and viability.

Infertility management may involve ovulation induction via Clomifene, or surgical repair of tubal obstructions. ART (IVF/ICSI) bypasses many natural fertilisation barriers. Ectopic pregnancies require urgent medical (methotrexate) or surgical (salpingectomy/salpingostomy) intervention depending on stability.